Publications by authors named "Gitasha Chand"

Claim this Profile
P
PD-L1 imaging with [Tc]NM-01 SPECT/CT is associated with metabolic response to pembrolizumab with/without chemotherapy in advanced lung cancer.
Daniel Johnathan Hughes, Gitasha Chand, Jessica Johnson, Ronan Tegala, Damion Bailey

Br J Cancer· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effects of anti-PD-1 therapy on programmed death-ligand 1 expression and glucose metabolism of normal organs in patients with advanced non-small cell lung cancer.
Matthew Severyn, Eunice H L Lee, Gitasha Chand, Jessica Johnson, Damion Bailey

BJR Open· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Tc]-labelled anti-Programmed Death-Ligand 1 single-domain antibody SPECT/CT: a novel imaging biomarker for myocardial PD-L1 expression.
Muhummad Sohaib Nazir, Daniel Johnathan Hughes, Gitasha Chand, Kathryn Adamson, Jessica Johnson

EJNMMI Res· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inter-rater and intra-rater agreement of [Tc]-labelled NM-01, a single-domain programmed death-ligand 1 (PD-L1) antibody, using quantitative SPECT/CT in non-small cell lung cancer.
Daniel Johnathan Hughes, Gitasha Chand, Jessica Johnson, Damion Bailey, Kathryn Adamson

EJNMMI Res· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tc‑labeled single-domain antibody for SPECT/CT assessment of HER2 expression in diverse cancer types.
Betül Altunay, Andreas Goedicke, Oliver H Winz, Fabian Hertel, Dirk von Mallek, Gitasha Chand

Eur J Nucl Med Mol Imaging· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retraction Note to: Inter- and intraobserver agreement of the quantitative assessment of [Tc]-labelled anti-programmed death-ligand 1 (PD-L1) SPECT/CT in non-small cell lung cancer.
Daniel Johnathan Hughes, Gitasha Chand, Vicky Goh, Gary J R Cook

EJNMMI Res· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inter- and intraobserver agreement of the quantitative assessment of [Tc]-labelled anti-programmed death-ligand 1 (PD-L1) SPECT/CT in non-small cell lung cancer.
Daniel Johnathan Hughes, Gitasha Chand, Vicky Goh, Gary J R Cook

EJNMMI Res· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early Phase I Study of a Tc-Labeled Anti-Programmed Death Ligand-1 (PD-L1) Single-Domain Antibody in SPECT/CT Assessment of PD-L1 Expression in Non-Small Cell Lung Cancer.
Yan Xing, Gitasha Chand, Changchun Liu, Gary J R Cook, Jim O'Doherty

J Nucl Med· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SPECT/CT imaging of chemotherapy-induced tumor apoptosis using Tc-labeled dendrimer-entrapped gold nanoparticles.
Yan Xing, Jingyi Zhu, Lingzhou Zhao, Zhijuan Xiong, Yujie Li, Gitasha Chand

Drug Deliv· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis